Investing Profile

Carol Gallagher

OperatorAdvisor
Venture Advisor at New Enterprise Associates (NEA)
nea.com/team/carol-gallagherCalifornia
Photo of Carol Gallagher, Advisor at New Enterprise Associates (NEA)
Your Intro Paths to Carol Gallagher

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Carol Gallagher on

cb
Current Investing Position
New Enterprise Associates (NEA) Advisor
Investments On Record
10
Current Fund Size
$6.2B

Carol Gallagher is on these Sector & Stage Rankings

Carol Gallagher's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Recludix Pharma
Series ANov 2021$60M
$60M
Co-investors: Matthew McAviney (New Enterprise Associates (NEA))
Millendo Therapeutics
Series UnknownAug 2018$30M
Series BJan 2016$62M
$110M
Co-investors: Bill Harrington (Osage University Partners), James N. Topper (Frazier Healthcare Partners)
Metacrine
Series CJun 2018$65M
Series BDec 2017$22M
$140M
Co-investors: Anup Arora (Hercules Capital)
Pionyr Immunotherapeutics
Series BDec 2017$62M
$79M
Co-investors: Leon Chen (The Column Group), Michael Powell (Omega Funds), Arjun Goyal (Vida Ventures), Jack Kenney (SV Health Investors)
Good2Go, Inc.
Seed RoundSep 2017$7M
$7M
Co-investors: Ruby Lee
Good2Go, Inc
SeedSep 2017$7M
$7M
Co-investors: Nancy Schoendorf (Mohr Davidow Ventures), Shailesh Rao (BigSpring), Corey Goodman (venBio)
Cleave Therapeutics
Series BAug 2016$37M
Series AApr 2013$10M
$100M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Kush Parmar (5am Ventures), Peter Thompson (OrbiMed), Andrew Schwab (5am Ventures), Marc Singer (Osage University Partners), Larry Lasky (The Column Group), Alfred Scheidegger (Nextech Invest)